ABAsim Fakhruddin Belagaumi

Asim Fakhruddin Belagaumi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Asim Fakhruddin Belagaumi has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Navigating the Planning and Initiation of a First Prospective Clinical Trial Through a Regional Pediatric Oncology Consortium Within the Middle East, Africa, and Asia—A Roadmap

    by Ruzanna Papyan, Farah Ghamloush, Iman Sidhom, Asim Belgaumi, Rihab Nasr, Iyad Sultan, Gevorg Tamamyan, Venkatraman Radhakrishnan, Carlos Rodriguez‐Galindo, Sima Jeha, et al.

    Background: Prospective pediatric oncology clinical trials remain scarce across low‐ and middle‐income countries (LMICs). We developed the first multicountry prospective clinical trial within the Pediatric Oncology East and Mediterranean (POEM) group. Localized osteosarcoma was selected due to heterogeneous real‐world management, including alternative regimens in settings where methotrexate administration is not feasible. This descriptive report details the feasibility of a regionally coordinated, resource‐adapted clinical trial across diverse LMIC settings. Methods: We describe the planning, capacity assessment, training, governance, and activation of POEM‐OS, a pragmatic two‐arm prospective cohort study evaluating MAP‐ and OS99‐based therapy for localized osteosarcoma. Preparation included a structured capacity‐mapping exercise across regional centers to assess clinical resources, research, and regulatory structures. The approach also encompassed designing a training program and communication through a structured study coordination team. Results: A total of 27 centers from 10 countries expressed intent to participate. A 12‐week virtual training curriculum was implemented for principal investigator and clinical research coordinator dyads, followed by an in‐person regional workshop. Eventually, 21 centers (8 countries) proceeded to study activation. Major barriers included heterogeneity in chemotherapy administration, high staff turnover, and variability in timelines to study‐agreement execution. Adaptive solutions included permanently accessible online training modules, simplified chemotherapy dosing, and harmonized toxicity grading. Centralized REDCap platforms enabled regional data sharing. By February 2026, the study had opened at 16 centers, with 21 patients enrolled. Conclusion: POEM‐OS demonstrates that a regionally directed, resource‐adapted clinical trial platform is feasible across diverse LMIC settings and establishes a foundation for sustainable regional clinical research infrastructure.

  • Clinical Research Capacity Building in Pediatric Oncology in Resource-Limited Settings: Application and Early Results of Regional Educational Workshops

    by Raya Saab, Rihab Nasr, Iman Sidhom, Asim Belgaumi, Meenakshi Devidas, Paula Naidu, Vaskar Saha, Iyad Sultan, Paola Friedrich, Mariam Fanous, et al.

    PURPOSE: The global need for training in clinical research is substantial, particularly in resource-limited settings. We describe an international collaboration to build capacity in clinical research skills through a semi-personalized curriculum. METHODS: Five sequential workshops (2020-2025) combined online modules with on-site, project-based learning. The curriculum across workshops included research project planning, proposal writing, and manuscript publishing. Topics included fundamentals of clinical study design, data registries, statistical considerations, research ethics, and scientific writing. At registration, applicants submitted an abstract for further development. An average of 35 applicants per workshop were selected. Participants' experiences were evaluated through postworkshop surveys. RESULTS: Participants across the workshops presented from 17 countries and seven disciplines, with the majority being physicians (66%) and nurses (16%). During each 2.5-day workshop, participants refined their abstracts with structured guidance and shared their work in a 10-minute presentation. Workshop 1 used a group-based model where each group developed one common Workshop 2 focused on quality improvement research; each group worked on preselected mock concepts through a structured learning exercise. Workshops 3 and 4 involved individualized learning, with each participant developing their own abstract into a study proposal. Workshop 5 focused on scientific writing, guiding participants to develop their abstracts into a manuscript outline. Surveys after each workshop consistently demonstrated a high level of satisfaction and perceived gain in knowledge and skill. CONCLUSION: These workshops effectively engaged trainees with various levels of clinical research training and imparted skills for research planning and manuscript writing. Future iterations will include thematic workshops including advanced statistical methods. Combining asynchronous learning modules with on-site, project-based training can be implemented across other regions and specialties in context-relevant settings.

  • Highlights From the 2025 Pediatric Oncology East and Mediterranean Biennial Conference: Advancing Pediatric Oncology Across the Eastern Mediterranean

    by Rawad Rihani, Sima Jeha, Luham Abu Rashida, Farah Ghamloush, Rihab Nasr, Mariam Fanous, Yara Sa'DEh, Asem Mansour, Asim Belgaumi, Carlos Rodriguez-Galindo, et al.

    PURPOSE: The Pediatric Oncology East and Mediterranean (POEM) Biennial Conference serves as a regional platform to advance childhood cancer care through scientific exchange, collaborative research, capacity building, and policy engagement. The 2025 Fourth Scientific Meeting aimed to showcase regional innovations, strengthen partnerships, and align strategies with the WHO Global Initiative for Childhood Cancer (GICC). METHODS: This report summarizes the scientific, clinical, and educational content of the 4th POEM Biennial Conference, held April 30-May 3, 2025, in Amman, Jordan, under the theme Harnessing Regional Strengths to Improve Equity, Access, and Quality Care . The program included plenary lectures, symposia, oral abstracts, posters, expert sessions, and focused workshops. RESULTS: The meeting attracted 351 delegates from 24 countries, including physicians, nurses, researchers, policymakers, and advocates. Scientific highlights featured the first regional multicenter outcomes of chimeric antigen receptor T-cell (CAR-T) therapy in low- and middle-income settings, updated survival data in acute lymphoblastic leukemia, and advances in hematopoietic cell transplantation using haploidentical and αβ T-cell–depleted grafts. Special sessions addressed CNS tumors, lymphomas, survivorship, gene therapy, and qualitative research. Advocacy panels highlighted equity and access for displaced and conflict-affected populations. Regional initiatives included strengthening the POEM Palliative Care and achieving consensus on early cancer detection strategies aligned with the WHO GICC. Pre- and post-conference workshops on artificial intelligence, sarcoma management, nursing leadership, and retinoblastoma delivered hands-on training and reinforced regional capacity building. Workshop evaluations demonstrated strong learning outcomes and a high likelihood of practice change. CONCLUSION: The 2025 POEM Biennial Conference reaffirmed the network's role as a catalyst for advancing childhood cancer care across the Eastern Mediterranean. By integrating scientific advances with strategies for equity, access, and policy reform, POEM continues to accelerate progress toward the global target of achieving at least 60% survival for all children with cancer by 2030.

  • Pediatric Oncology Surgery: Research Methodology

    by Ayesha Arshad Ali, Miriam Hwang, Scott C. Howard, Asim Belgaumi

  • Using Research Capacity Enhancement to Develop and Implement National Standard-of-Care Treatment Protocols in Pakistan

    by Mohiba A. Khowaja, Alia Ahmad, Sadaf Altaf, Sadia Anwar, Mahwish Faizan, Tariq Ghafoor, Uzma Imam, Zulfiqar Ali Rana, Rabia Wali, Nuzhat Yasmeen, et al.

    PURPOSE: Utilization of clinical research methodology as a means for improvement in pediatric cancer outcomes is well established. Toward achievement of its WHO-Global Initiative for Childhood Cancer (GICC) goals in Pakistan, the Pakistan Society of Pediatric Oncology (PSPO) has used this methodology to develop and implement standard-of-care (SOC) protocols nationally, with centralized research and data management support. This article describes the strategy for its implementation and provides a foundation for future advancements in cancer care in Pakistan. METHODS: The following steps were used to achieve the objectives: Central Support: A central PSPO office was established with minimal required staffing for provision of support to clinicians for protocol development and implementation and housing data and documents. Clinical protocols: multi-institutional teams, supported by central staff, developed SOC protocols on the basis of international evidence and local experience for six GICC target diagnoses. These went through an iterative consultation and revision process and were finally approved by the PSPO Board. Protocol implementation: case report forms and databases were developed using RedCap software and tested for functionality. Education and training were provided to institutional principal investigators and data entry personnel on the disease, protocol, use of RedCap, and data entry. Data quality maintenance: a system was established for ongoing data quality maintenance through central support and augmented by virtual and on-site audits. Where required, targeted training was provided. Interim analyses are being performed to assess data quality and early outcomes. RESULTS: Development and implementation of protocols occurred over 26 months. Each protocol is currently active in at least seven centers. Almost 2,000 patients have been enrolled. Interim analysis of ALL data shows 85% data accuracy. CONCLUSION: Research infrastructure and capacity building for implementation of multi-institutional treatment protocols in low- and middle-income countries with modest resources is feasible.


  • Open Access

    Paediatric oncology in the Eastern Mediterranean region (EMR): the current state and challenges

    by Arsalan Kabir Siddiqui, Asim Fakhruddin Belgaumi

    Paediatric oncology in the Eastern Mediterranean region (EMR): the current state and challenges Arsalan Kabir Siddiqui† and Asim Fakhruddin Belgaumi†,a


  • Open Access

    Global Immunization Crisis Amid the COVID-19 Pandemic: Implications for Pediatric Oncology

    by Syed Ibrahim Bukhari, Fyezah Jehan, Asim Belgaumi

    Declining herd immunity and severe manifestation of vaccine preventable infections underscores the need for vaccinations campaigns to urgently vaccinate children who missed their routine immunizations.


  • Pediatric Oncology Surgery: Research Methodology

    by Ayesha Arshad Ali, Miriam Hwang, Scott C. Howard, Asim Belgaumi

  • Open Access

    Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region

    by Raya Saab, Victor Santana, Anas Obeid, Meenakshi Devidas, Asim Belgaumi, Nickhill Bhakta, Paula Naidu, Vaskar Saha, Iyad Sultan, Ramandeep Singh Arora, et al.

    PURPOSE: Formal training in clinical research methodologies is limited in limited-resource countries. Through collaboration among high- and middle-resource settings and in response to an identified need verbalized by regional pediatric oncology practitioners, Pediatric Oncology East & Mediterranean Group and St Jude Global developed a workshop focused on capacity building in research skills. Here, we describe its structure, implementation, and early results. METHODS: Leveraging virtual capabilities, the format included lectures and small group breakout exercise sessions, for 3 hours per day on 2 consecutive days per week for 2 consecutive weeks. Topics included basics of study design, introduction to health care statistics, research ethics, data registries, and scientific writing. Applicants were required to submit an abstract for a potential research project. Each breakout group selected one abstract for further development and presented the final version in a groupwide session. The participants' experience was evaluated through an online survey. RESULTS: Attendance included 29 registrants from 12 countries and six disciplines. Each breakout group was assigned a themed category: cohort studies, clinical trials, or registries. Critical feedback from the breakout sessions helped strengthen the selected projects, which included a retrospective study, a prospective observational study, a prospective interventional study, and a registry proposal. After the workshop, participants were invited to further develop their original abstracts, and three proposals received additional mentoring, one of which was a multi-institutional prospective study that was subsequently submitted through the Pediatric Oncology East & Mediterranean Group network for implementation. The postworkshop survey revealed an overall highly positive experience, and feedback provided potential themes for future workshops. CONCLUSION: This workshop demonstrated the potential for collaborative network partnerships in targeting research training gaps in pediatric oncology. Lessons learned will be applied to future workshops to strengthen research in limited-resource settings.